China’s biotech and healthcare sectors are evolving at extraordinary speed — from AI-powered “doctor avatars” and digital health super apps to a wave of Chinese drug innovation reshaping the global pharmaceutical industry.
In this episode, I speak with physician and healthcare strategist Dr. Ruby Wang about the latest trends in China's AI + healthcare innovation.We discuss:
Why Western pharma companies are rushing to license Chinese drugs
China’s rise as a global biotech powerhouse
AI doctors, digital hospitals, and health super apps
The role of Alibaba, Ant Group, and DeepSeek in healthcare
Why China’s healthcare digitization is moving faster than the West
The future of AI in medicine and diagnosticsChinese medical devices, robotics, and healthcare hardware
How Chinese regulators accelerated biotech innovation
Whether healthcare can become China’s next major global export industry
The challenges China still faces in healthcare access and inequality
Ruby Wang is a UK-trained physician, founder of China Health Pulse, and author of the upcoming book China Cure, which explores the global impact of China’s biotech and AI healthcare advances.
Links:
China Health Pulse newsletter and podcast: https://www.chinahealthpulse.com/
For transcripts and more, check out the High Capacity newsletter: https://www.highcapacity.org/
More about the host, Kyle Chan: https://www.kyleichan.com/
Podden och tillhörande omslagsbild på den här sidan tillhör
Kyle Chan. Innehållet i podden är skapat av Kyle Chan och inte av,
eller tillsammans med, Poddtoppen.
